ClinConnect ClinConnect Logo
Search / Trial NCT04725006

Sensory Responses to Dorsal Root Stimulation

Launched by LEE FISHER, PHD · Jan 21, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Spinal Cord Stimulation Dorsal Root Ganglia Stimulation Sensation Amputation Pain

ClinConnect Summary

This clinical trial is exploring how electrical stimulation of the spinal cord can create different sensations in people who have had amputations or experience phantom pain. The researchers aim to understand how to control the type, strength, and location of these sensations using a spinal cord stimulator device. If you are between 18 and 70 years old and are already part of a trial using a similar spinal cord device for pain management, you may be eligible to participate.

Participants in this study will connect their spinal cord stimulator to a special system that allows researchers to adjust settings and observe the sensations experienced. They will be asked to describe what they feel, helping scientists learn more about how our nervous system works. It’s important to note that individuals with certain medical conditions, such as open wounds or implanted metal devices, will not be able to join this trial. This study could provide valuable insights into improving pain management for those with similar conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subjects must be between the ages of 18 and 70 years old.
  • 2. Subjects must be undergoing an epidural spinal cord implanted electrode array clinical trial with Dr. Helm for the management of pain.
  • 3. Persons must understand the consent and the procedures.
  • Exclusion Criteria:
  • 1. Persons with open wounds;
  • 2. Persons with implanted metal rods in the spine or limbs;
  • 3. Persons with defibrillator or pacemaker;
  • 4. Persons with permanent skin metal tags or decorations.

About Lee Fisher, Phd

Dr. Lee Fisher, PhD, is a distinguished clinical trial sponsor with extensive expertise in the design and management of innovative research studies. With a strong foundation in clinical pharmacology and a commitment to advancing medical science, Dr. Fisher leads initiatives that focus on developing novel therapeutic interventions. His comprehensive understanding of regulatory requirements and dedication to patient safety ensure that each trial adheres to the highest ethical standards, fostering collaboration among multidisciplinary teams. Dr. Fisher's strategic vision and rigorous scientific approach position him as a key contributor to the advancement of healthcare solutions.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Lee Fisher, PhD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials